RedHill Biopharma (NASDAQ: RDHL) reported Q4 operating loss of $20.7 million. Revenue for the quarter came in at $22.1 million versus the consensus estimate of $24.08 million.

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.